haematology
Blood cancers

New approach needed on adverse events in haematological cancers

An international group of experts in haematology have called for an urgent review of the way adverse events in haematological cancers are reported and managed. In an era when targeted therapies have transformed previously incurable blood cancers to allow patients to live with disease for many years, the traditional focus on acute high grade adverse ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic